Pictured: Ping Chi
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Pictured: Scott Lowe
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, September 30, 2014

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.

Pictured: Experimental Brain Tumor
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 18, 2014

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Pictured: Nematode Worm Embryo
Snapshot
By Jennifer Bell, PhD  |  Thursday, September 11, 2014

Stunning movies captured in the lab of computational biologist Zhirong Bao reveal how cells divide, grow, and move around, as in a carefully choreographed dance, during the development of a nematode worm embryo.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 4, 2014

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.

In the Clinic
By Jennifer Castoro, BA, Managing/Copy Editor  |  Thursday, September 4, 2014

Researchers have found that in a subset of women, consumption of soy could boost the expression of genes linked to breast cancer.

Pictured: Johanna Joyce
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Tuesday, August 19, 2014

A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.

Lab mouse with cultured human pluripotent stem cells
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, August 7, 2014

Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.

Pictured: Marc Ladanyi
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, August 6, 2014

A newly discovered gene mutation appears to be the driving force behind a particularly aggressive form of embryonal rhabdomyosarcoma, a rare cancer of the skeletal muscle.

Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, August 4, 2014

Memorial Sloan Kettering investigator Ann Zauber answers questions about the risks and benefits of colon cancer screening in the elderly.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, July 28, 2014

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

Pictured: Robotic surgery
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, July 24, 2014

Memorial Sloan Kettering researchers have found that the use of surgical robots does not lead to better outcomes in patients undergoing radical cystectomy for bladder cancer, bringing into question the added costs of the tools.

Pictured: Gabriela Chiosis
Finding
By Celia Gittelson, BA  |  Thursday, July 17, 2014

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Pictured: Gum ball machines
Decoder
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, July 2, 2014

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.

Pictured: Serge Lyashchenko
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, June 27, 2014

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.

Center News

Stay Informed

Get the latest information about cancer care and research every month.